GDF has a rigorous quality assurance policy in place to guarantee the safety, efficacy, and quality of the products it provides. This comprehensive policy is guided by WHO standards and policies and aligns closely with the policies of other UN agencies, key technical partners and international non-governmental agencies.

Products procured through GDF should meet quality assurance criteria, and must be either prequalified by WHO, or authorized for use by a Stringent Regulatory Authority (SRA) as defined and listed by WHO or be recommended for short-term procurement by the Expert Review Panel (ERP).

All products must be approved for procurement and use by relevant national medicine regulatory authorities. In vitro diagnostic and medical devices must comply with the quality standards and referential norms set by the WHO Global Laboratory Initiative, WHO Prequalification of In Vitro Diagnostics Programme; WHO Department of Essential Health Technologies and WHO consolidated guidelines on Tuberculosis.

GDF contracts external internationally accredited or certified quality control and inspection Agents to carry out independent pre-shipment inspections, sampling and testing of medicines and diagnostics.

For further information, please refer to GDF’s quality assurance policy and GDF Drug Monitoring Programme.

 

QA Notifications: